前收市價 | 5.40 |
開市 | 7.00 |
買盤 | 5.90 |
賣出價 | 9.00 |
拍板 | 33.00 |
到期日 | 2024-06-28 |
今日波幅 | 7.00 - 7.00 |
合同範圍 | 無 |
成交量 | |
未平倉合約 | 1 |
Immunovant stock slumped Thursday — reversing a day-earlier jump — after pivoting its focus to what one analyst called "a backup compound."
Immunovant (IMVT) declines 5% on dismal fourth-quarter fiscal 2024 results. The company names IMVT-1402 as its new lead candidate to initiate several studies for autoimmune indications.
Biohaven stock tumbled Wednesday after the company's experimental protein-degrading drug lagged investor expectations.